PT - JOURNAL ARTICLE AU - Sharma, Priyanka AU - Basu, Sandip TI - Occurrence of the Redifferentiation-Akin Phenomenon on <sup>68</sup>Ga-DOTATATE PET/CT After CAPTEM Chemotherapy in Metastatic Neuroendocrine Tumors with Intermediate MIB1 Index: What Could Be the Molecular Explanation? AID - 10.2967/jnmt.120.241539 DP - 2020 Sep 01 TA - Journal of Nuclear Medicine Technology PG - 290--291 VI - 48 IP - 3 4099 - http://tech.snmjournals.org/content/48/3/290.short 4100 - http://tech.snmjournals.org/content/48/3/290.full SO - J. Nucl. Med. Technol.2020 Sep 01; 48 AB - In this report, we present the 68Ga-DOTATATE PET/CT images of a patient with a metastatic neuroendocrine tumor with an intermediate-grade/Ki-67 index who had minimal somatostatin receptor positivity on baseline 68Ga-DOTATATE PET/CT but high-grade positivity on somatostatin receptor imaging (Krenning score, III–IV) on follow-up scans after chemotherapy. This redifferentiation-akin phenomenon in intermediate-grade neuroendocrine tumors after chemotherapy can have potential implications for the feasibility of peptide receptor radionuclide therapy in this group of patients in the later phase of their disease course.